(Q49043230)

18 February 2018

title

Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis. (English)

1 reference

18 February 2018

juvenile neuronal ceroid lipofuscinosis

main subject

0 references

1 reference

Lamminranta S

1

1 reference

18 February 2018

Aberg LE

2

1 reference

18 February 2018

Autti T

3

1 reference

18 February 2018

Moren R

4

1 reference

18 February 2018

Laine T

5

1 reference

18 February 2018

Kaukoranta J

6

1 reference

18 February 2018

Santavuori P

7

1 reference

18 February 2018

publication date

1 February 2001

1 reference

18 February 2018

Journal of Intellectual Disability Research

published in

1 reference

18 February 2018

volume

45

1 reference

18 February 2018

issue

Pt 1

1 reference

18 February 2018

page(s)

8-17

1 reference

18 February 2018

MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2001.00288.X

Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2001.00288.X

Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2001.00288.X

Rapid diagnostic test for the major mutation underlying Batten disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2001.00288.X

Neuroimaging in pediatric epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2001.00288.X

Brain perfusion SPECT in juvenile neuronal ceroid lipofuscinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2001.00288.X

Psychological symptoms and sleep disturbances in neuronal ceroid-lipofuscinoses (NCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2001.00288.X

Experience of Antioxidant Treatment in Neuronal Ceroid-Lipofuscinosis of Spielmeyer-Sjögren Type1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2788.2001.00288.X

10.1046/J.1365-2788.2001.00288.X

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018